Artemis Medicare Services Limited

NSEI:ARTEMISMED Voorraadrapport

Marktkapitalisatie: ₹39.5b

Artemis Medicare Services Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Artemis Medicare Services is de winst gegroeid met een gemiddeld jaarlijks percentage van 36.6%, terwijl de Healthcare industrie de winst jaarlijks groeide met 28.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 21.9% per jaar. Het rendement op eigen vermogen van Artemis Medicare Services is 12.3%, en het heeft een nettomarge van 6.3%.

Belangrijke informatie

36.6%

Groei van de winst

35.9%

Groei van de winst per aandeel

Healthcare Groei van de industrie29.4%
Inkomstengroei21.9%
Rendement op eigen vermogen12.3%
Nettomarge6.3%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

Jul 16
Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Apr 13
After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Jun 14
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Mar 15
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Aug 31
Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Jul 30
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

May 13
Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Jan 11
Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Dec 10
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Sep 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Jul 01
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

May 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Mar 16
We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Jan 22
Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Nov 13
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Jul 20
Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Opbrengsten en kosten

Hoe Artemis Medicare Services geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NSEI:ARTEMISMED Opbrengsten, kosten en inkomsten (INR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 248,922560850
31 Mar 248,786491850
31 Dec 238,4864561060
30 Sep 238,1734451060
30 Jun 237,7974001060
31 Mar 237,3743861060
31 Dec 226,916412600
30 Sep 226,482373600
30 Jun 225,997363600
31 Mar 225,548318600
31 Dec 215,345313360
30 Sep 215,147301360
30 Jun 214,680221360
31 Mar 214,08465360
31 Dec 204,177-19540
30 Sep 204,370-16540
30 Jun 204,9203800
31 Mar 205,650198540
31 Dec 195,667211720
31 Mar 195,465205720
31 Mar 185,028268990
31 Mar 174,5902711190
31 Mar 164,0182161070
31 Mar 153,675186740

Kwaliteitswinsten: ARTEMISMED heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (6.3%) ARTEMISMED } zijn hoger dan vorig jaar (5.1%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van ARTEMISMED is de afgelopen 5 jaar aanzienlijk gegroeid met 36.6% per jaar.

Versnelling van de groei: De winstgroei van ARTEMISMED over het afgelopen jaar ( 40% ) overtreft het 5-jarig gemiddelde ( 36.6% per jaar).

Winst versus industrie: De winstgroei ARTEMISMED over het afgelopen jaar ( 40% ) overtrof de Healthcare -sector 30.6%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 12.3% ) van ARTEMISMED wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden